Hongbo Zhang, Hélder A. Santos and colleagues from University of Helsinki, Åbo Akademi University and Harvard University have applied nanotechnology to fabricate a specific nanomedicine that can fit this purpose.

Cancer is a very complex and serious disease that greatly threatens human health and challenges current medication, owing to multiple cancer specific barriers, intratumoral heterogeneity, individual differences in patients, the multiple drug resistance effect, as well as severe side effects of anticancer drugs. It is attractive and highly desirable to develop novel methodologies for cancer treatment to overcome the obstacles that arise from drug-based cancer therapy.

This novel design of nanovectors opens up new pathways for cancer targeting and therapy, while providing a new horizon for the engineering of novel anti-cancer nanomedicines.

Read more at Advanced Science News website